ISRCTN89151172Completed未知
Acute effects of electronic cigarette on pulmonary function and exhaled inflammatory mediators in patients with asthma
Pulmonary Clinic and Respiratory Failure Unit of Aristotle University of Thessaloniki, General Hospital of Thessaloniki ''Georgios Papanikolaou''0 sites50 target enrollmentStarted: August 8, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
2020 results in https://pubmed.ncbi.nlm.nih.gov/32239706 (added 07/04/2020)
Study Design
- Study Type
- Other
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Asthma patients:
- •1. Every-day smoker:
- •1.1. Smoked at least 100 cigarettes in their lifetime
- •1.2. Smoke every day at the time of research
- •2. Moderate asthma
- •3. Aged over 18 years old
- •Healthy controls:
- •1. Every-day smoker:
- •1.1. Smoked at least 100 cigarettes in their lifetime
- •1.2. Smoke every day at the time of research
- •2. Visited the smoking cessation clinic or other pulmonary dispensaries of the hospital during the research
- •3. Aged over 18 years old
- •Healthy controls were matched with asthma patients on baseline characteristics including age, gender, height, weight, BMI and number of pack-years.
Exclusion Criteria
- •For the group of asthma patients:
- •1. Mild or severe asthma and not receiving therapy of step 3 according to 2016 GINA guidelines
- •2. Any chronic disease other than asthma
- •3. Acute asthma exacerbation the last month before the study
- •4. Use of corticosteroids
- •5. Any acute disease 2 weeks prior to the study.
- •6. Use of any medication except for asthma treatment currently or in the 2 weeks prior to study participation
- •7. Having smoked since their morning awakening and/or had an Exhaled CO measurement of over 5 ppm the day they would take part in the study
- •For the control group:
- •1. Any chronic disease
- •2. Any acute disease currently or in the 2 weeks prior to study participation
- •3. Having smoked since their morning awakening and/or had an Exhaled CO measurement of over 5 ppm the day they would take part in the study
Investigators
Similar Trials
Completed
Not Applicable
ong-term consequences of COVID-19 for pulmonary and neurocognitive disordersDRKS00023806Klinik für Neurodegenerative Erkrankungen und GerontopsychiatrieUniversitätsklinikum Bonn162
Completed
Not Applicable
The effect of mistimed mechanical breathing assistance on patient outcomesISRCTN17848241Sir Run Run Shaw Hospital, school of medicine, Zhejiang university300
Not yet recruiting
Not Applicable
ong term Effects of Covid on Pulmonary Function and Quality of Life.CTRI/2022/01/039307one
Completed
Not Applicable
Prevalence and predictors of complications during sedation for paediatric gastrointestinal endoscopyISRCTN70362666niversitair Ziekenhuis Brussel3,435
Completed
Not Applicable
Evaluation Of The Chronic Effects Of Covıd-19 Infection On The Respiratory SystemPost-COVID-19 SyndromeCOVID-19NCT06439134Yeditepe University100